Healint's CEO Francois Cadiou and Global Partnership Director Susanna Hasenoehrl joined the Asia Pacific Medical Technology Association (APACMed)'s quarterly gathering in Singapore today.
Read MoreHealint joined the panel on The Impact of Artificial Intelligence on Achieving the Sustainable Development Goals organised by SGInnovate on August 6th in Singapore.
Read MoreAs read in the press: ‘A one-of-a-kind AI startup, Healint’s machines digest data and real-world evidence for patients looking to control mind-splitting migraines. Healint’s app, Migraine Buddy is the most popular condition-specific app in the world.’
Read MoreAccording to Danny Bar-Zohar, the global head of neuroscience development at Novartis, real-world experience is valuable not only for future drug development and broader disease management approaches but also for current educational, tele-coaching and digital solutions to help migraine sufferers with daily challenges.
Read More'Migraine Buddy increases patient engagement and helps patients become more cognizant of how migraine attacks start and how to treat them. It also allows patients to provide their physician with a summary of migraine symptoms, frequency, and previous treatments.'
Read MoreTogether with leading experts in neurology, telemedicine and digital, Novartis pilots an employee migraine support program with Healint to address the burden of migraine at workplace.
Read MoreHealint’s Head of Data at Echelon Singapore #echelon18
Read MoreLatest research featuring Migraine Buddy insights puts the cost of migraine to the economy in UK to £3.3 billion and in France to €3.8 billion a year
Read More